UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036358
Receipt number R000040185
Scientific Title Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety -
Date of disclosure of the study information 2019/03/31
Last modified on 2019/03/31 13:22:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety -

Acronym

Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety -

Scientific Title

Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety -

Scientific Title:Acronym

Sentinel lymphnode biopsy treated with local anesthesia - efficacy and safety -

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

efficacy and safety of Sentinel lymphnode biopsy treated with local anesthesia

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

detection rate of sentinel lymphnode

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine Maneuver

Interventions/Control_1

pretreat with local anesthesia ahead of RI injection

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Female

Key inclusion criteria

application of sentinel lymph node biosy
no allergy against local anesthesia
informed consent

Key exclusion criteria

allergy against local anesthesia

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Shinichiro
Middle name
Last name Kubo

Organization

Fukuyama City Hospital

Division name

Breast and Thyroid Surgery

Zip code

721-8511

Address

Zao-cho 5-23-1, Fukuyama, Hiroshima, Japan

TEL

084-941-5151

Email

Shimin-byouin@city.fukuyama.hiroshima.jp


Public contact

Name of contact person

1st name Shinichiro
Middle name
Last name Kubo

Organization

Fukuyama City Hospital

Division name

Breast and Thyroid Surgery

Zip code

721-8511

Address

Zao-cho 5-23-1, Fukuyama, Hiroshima, Japan

TEL

084-941-5151

Homepage URL


Email

Shimin-byouin@city.fukuyama.hiroshima.jp


Sponsor or person

Institute

Fukuyama City Hospital

Institute

Department

Personal name



Funding Source

Organization

Fukuyama City Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB(Fukuyama City Hospital)

Address

Zao-cho 5-23-1, Fukuyama, Hiroshima, Japan

Tel

084-941-5151

Email

Shimin-byouin@city.fukuyama.hiroshima.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2019 Year 02 Month 04 Day

Date of IRB

2019 Year 02 Month 04 Day

Anticipated trial start date

2019 Year 02 Month 04 Day

Last follow-up date

2019 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 03 Month 31 Day

Last modified on

2019 Year 03 Month 31 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040185


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name